Pricing Log in Create free account

INmune Bio, Inc. (INMB) vs LianBio Sponsored ADR (LIANY)

INmune Bio, Inc. and LianBio Sponsored ADR are both Biotechnology companies. INmune Bio, Inc. and LianBio Sponsored ADR are of similar size ($34.2M and $32.6M). INmune Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. Across the 10 metrics below, LianBio Sponsored ADR leads on 8 and INmune Bio, Inc. on 2.

Valuation

Metric INMB LIANY Biotechnology median
P/E n/m 0.01 10.60
P/S 221.67 n/m 9.40
P/B 1.47 0.01 2.13
Price to free cash flow n/m 0.02 25.18
EV/EBITDA n/m 5.73 0.66
EV/Sales 121.37 n/m 9.02
Earnings yield (59.82%) 7,216.75% (32.88%)
Free cash flow yield (54.91%) 5,994.86% (23.13%)

Profitability

Metric INMB LIANY Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (74.82%) 70.96% (51.96%)
Return on assets (57.08%) 66.19% (46.06%)
Return on invested capital (646.94%) (450.47%) 0.00%

Growth

Metric INMB LIANY Biotechnology median
Revenue growth (TTM) (51.61%) — 6.76%
EPS growth (last fiscal year) 11.85% 75.44% 29.88%
Revenue growth, 5-year CAGR 35.37% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INMB LIANY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.04 17.03 4.97
Net debt to EBITDA 0.52 7.41 1.01

Dividend

Metric INMB LIANY Biotechnology median
Dividend yield — 0.00% 0.41%
Payout ratio — — —

Size

Metric INMB LIANY Biotechnology median
Market cap 32.61m 34.19m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack